The FDA issued warning letters to 30 telehealth companies over misleading claims about compounded versions of popular ...

New research suggests GLP-1 drugs may increase the risk of bone and tendon injuries and other conditions, including ...

The blockbuster GLP-1 drugs that have reshaped the treatment of diabetes and obesity may help prevent multiple substance use ...

Glucagon-like peptide 1 (GLP-1) receptor agonists are a class of Type 2 diabetes drugs that improves blood sugar and may also lead to weight loss. These drugs — including ...

Tirzepatide (Zepbound, Mounjaro) is a dual-agonist GLP-1 medication. It works like a GLP-1 agonist, but also targets a ...

People struggling with many addictions, ranging from opioids to gambling, are reporting similar experiences in clinics, on ...

Drug executives say only their GLP-1 drugs are safe for treating obesity and diabetes as they wage a year-long campaign to ...

A November 2025 Kaiser Family Foundation poll found that 1 in 8 U.S. adults have tried a GLP-1 medication for weight loss, diabetes or another condition. And we expect that number to rise now that one ...

The Navitus survey also found that nearly 60% of users are aware of safety concerns tied to compounded GLP-1 products. More than 86% said they would be willing to pay more for an FDA-approved ...

Consumer health advertising is driving many employees to take action on GLP-1s. But without guidance, those decisions could be risky.

Semaglutide, active ingredient in popular weight-loss drugs, including Ozempic and Wegovy, belongs to the class of ...

Wellness Trends & Global Expansion Are Shaping Fitness in 2026 Vancouver, Canada – March 4, 2026 / All Things Fitness & ...